The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Taylor Ben R since 2019.
This trader's CIK number is 1712276.
At the time of last reporting, Taylor Ben R was the Chief Financial Officer of Recursion Pharmaceuticals, Inc.. (stock ticker symbol RXRX).
Also see all insider trading activities at Recursion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | TYME | 10,000 | $10,100 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | RXRX | 0 | $0 | 21,383 | $89,380 | 0 | $0 |
1. Tyme Technologies, Inc. (TYME)
2. Recursion Pharmaceuticals, Inc. (RXRX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-06-14 | TYME | Buy | 10,000 | 1.01 | 10,100 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-12-29 | RXRX | Sale | 21,383 | 4.18 | 89,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Taylor Ben R (Chief Financial Officer of Recursion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.